Skip Navigation

European Heart Journal 2003 24(6):499-500; doi:10.1016/S0195-668X(02)00810-2
Copyright © 2003 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Eidelman, R. S
Right arrow Articles by Hennekens, C. H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eidelman, R. S
Right arrow Articles by Hennekens, C. H
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

Fibrinogen: a predictor of stroke and marker of atherosclerosis

Rachel S Eidelman* and Charles H Hennekens

Department of Cardiology, Mount Sinai Medical Center-Miami Heart Institute, 4300 Alton Road, Suite 207A, Miami Beach, FL 33140, USA and the Departments of Medicine & Epidemiology and Public Health, University of Miami School of Medicine

* Corresponding author. Tel.: +1-305-674-2567; fax: +1-305-674-2146
E-mail address: drseidelman@aol.com

The first 10% of the full text of this article appears below.

See doi:10.1016/S1095-668X(02)00467-0for the article to which this editorial refers.

Fibrinogen was demonstrated, more than 40 years ago, to be elevated among patients with acute thrombosis. The first prospective study to show an association between fibrinogen levels and subsequent cardiovascular disease risk was the Gothenburg Heart Study from Sweden in 1984.1 In the Northwick Park Heart Study2 from the UK, fibrinogen and factor VII appeared to be as effective as total . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques: The Copenhagen City Heart Study
S.C. Kofoed, H.H. Wittrup, H. Sillesen, and B.G. Nordestgaard
EHJ 2003 24: 567-576. [Abstract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 Eur Heart JHome page
J. F Viles-Gonzalez, V. Fuster, and J. J Badimon
Atherothrombosis: A widespread disease with unpredictable and life-threatening consequences
Eur. Heart J., July 2, 2004; 25(14): 1197 - 1207.
[Abstract] [Full Text] [PDF]